Sakura Finetek Europe manufactures integrated histopathology systems and consumables for cancer diagnosis. The company is investing heavily in automation and IT architecture modernization—adopting PowerShell and Mendix, and scaling support and engineering teams across seven European countries—while wrestling with Oracle environment stability and process automation implementation gaps in lab workflows.
Sakura Finetek Europe, headquartered in Alphen aan den Rijn, Netherlands, designs and manufactures equipment and consumables for anatomic pathology labs. The product portfolio spans histopathology instruments, lab automation systems, and diagnostic consumables, sold to hospital and independent pathology labs across Europe. The company operates on an Oracle Cloud infrastructure (ERP, CRM, HCM, CPQ) with emerging investments in low-code automation (Mendix) and IT strategy overhaul. Support and engineering roles dominate the current hiring pipeline, reflecting both customer-facing demand and internal modernization efforts.
Sakura manufactures histopathology instruments, lab automation solutions, and consumables for cancer diagnosis. The company serves pathology labs and hospitals across Europe with integrated anatomic pathology systems.
Sakura runs on Oracle Cloud (ERP, CRM, CPQ, HCM), Microsoft 365 / Azure, and TOPdesk. The company is adopting Mendix for low-code automation and PowerShell for infrastructure management.
Other companies in the same industry, closest in size